Top

Osteoporosis International

Published in:

01-04-2007 | Original Article

Bone microarchitecture in males with corticosteroid-induced osteoporosis

Authors: D. Chappard, N. Josselin, C. Rougé-Maillart, E. Legrand, M. F. Baslé, M. Audran

Published in: Osteoporosis International | Issue 4/2007

Abstract

Summary

Microarchitectural changes in trabecular bone were analyzed by microcomputed tomography (microCT) and histomorphometry in 24 patients with corticosteroid-induced osteoporosis. The microCT images revealed a reduction in trabecular thickness only on frequency distribution curves, with no increase in trabecular separation. Trabecular plate thinning and perforations were easily identified.

Introduction

Corticosteroid-induced osteoporosis (CSIOP) is mediated by direct actions of the drug on bone cells. The result is a decrease in trabecular bone mass and a reduction in trabecular thickness, but connectivity is believed to remain rather well preserved.

Methods

Twenty-four transiliac bone biopsies from patients with CSIOP were studied conjointly by histomorphometry [with two-dimensional (2D) architectural descriptors] and microCT (with 3D analysis of trabecular characteristics, including trabecular thickness and separation). The frequency distribution of thickness and separation were compared with data obtained in nine control subjects.

Results

2D histomorphometry revealed a decrease in bone volume and trabecular thickness in the bone biopsies of the CSIOP patients when compared to those of the controls. MicroCT appeared to be able to identify the reduction in thickness only when the frequency distribution of trabecular thickness was computed. No difference for the curves of the frequency distribution of trabecular separation was evidenced between patients and controls. MicroCT and 2D histomorphometric results were correlated, but 2D analysis appeared to be more sensitive. However, microCT identified a very specific thinning of the trabecular plates in their center that corresponds to the earlier stages of perforations.

Conclusion

Trabecular plate thinning can be observed and perforations occur on very thin plates in CSIOP patients.

Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112:352–364PubMed

Cooper C, Coupland C, Mitchell M (1995) Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 54:49–52PubMedCrossRef

van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology 39:1383–1389PubMedCrossRef

van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787PubMedCrossRef

Hahn TJ, Halstead LR, Baran DT (1981) Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab 52:111–115PubMedCrossRef

Braun JJ, Juttmann JR, Visser TJ, Birkenhager JC (1982) Short-term effect of prednisone on serum 1,25-dihydroxyvitamin D in normal individuals and in hyper- and hypoparathyroidism. Clin Endocrinol 17:21–28

Paz-Pacheco E, Fuleihan GE, LeBoff MS (1995) Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects. J Bone Miner Res 10:1713–1718PubMed

Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ (2001) Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res 16:97–103PubMedCrossRef

Sasaki N, Kusano E, Ando Y, Nemoto J, Iimura O, Ito C, Takeda S, Yano K, Tsuda E, Asano Y (2002) Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis. Bone 30:853–858PubMedCrossRef

10.

LoCascio V, Bonucci E, Imbimbo B, Ballanti P, Adami S, Milani S, Tartarotti D, DellaRocca C (1990) Bone loss in response to long-term glucocorticoid therapy. Bone Miner 8:39–51PubMedCrossRef

11.

Hall GM, Spector TD, Delmas PD (1995) Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. Arthritis Rheum 38:902–906PubMedCrossRef

12.

Dolan AL, Moniz C, Dasgupta B, Li F, Mackintosh C, Todd P, Corrigall V, Panayi GS (1997) Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica. Arthritis Rheum 40:2022–2029PubMedCrossRef

13.

Aaron JE, Francis RM, Peacock M, Makins NB (1989) Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. Clin Orthop 243:294–305

14.

Dempster DW, Arlot MA, Meunier PJ (1983) Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int 35:410–417PubMedCrossRef

15.

Lems WF, Gerrits MI, Jacobs JW, van Vugt RM, van Rijn HJ, Bijlsma JW (1996) Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann Rheum Dis 55:288–293PubMed

16.

Ali NJ, Capewell S, Ward MJ (1991) Bone turnover during high dose inhaled corticosteroid treatment. Thorax 46:160–164PubMedCrossRef

17.

Chappard D, Legrand E, Baslé MF, Fromont P, Racineux JL, Rebel A, Audran M (1996) Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study. J Bone Miner Res 11:676–685PubMed

18.

Chappard D, Legrand E, Pascaretti C, Audran M, Baslé MF (1999) Comparison of eight histomophometric methods for measuring trabecular bone architecture by image analysis on histological sections. Microsc Res Techniq 45:303–312CrossRef

19.

Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595–610PubMed

20.

Parfitt AM, Matthews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS (1983) Relationships between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72:1396–1409PubMed

21.

Le HM, Holmes RE, Shors E, Rosenstein DA (1992) Computerized quantitative analysis of the interconnectivity of porous biomaterials. Acta Stereol 11S1:267–272

22.

Croucher PI, Garrahan NJ, Compston JE (1996) Assessment of cancellous bone structure: comparison of strut analysis, trabecular bone pattern factor, and marrow space star volume. J Bone Miner Res 11:955–961PubMed

23.

Hildebrand T, Ruegsegger P (1997) A new method for the model-independent assessment of thickness in three-dimensional images. J Microsc 185:67–75CrossRef

24.

Fajardo RJ, Müller R (2001) Three-dimensional analysis of nonhuman primate trabecular architecture using micro-computed tomography. Am J Phys Anthropol 115:327–336PubMedCrossRef

25.

Birkenhager-Frenkel DH, Courpron P, Hupscher EA, Clermonts E, Coutinho MF, Schmitz PI, Meunier PJ (1988) Age-related changes in cancellous bone structure. A two-dimensional study in the transiliac and iliac crest biopsy sites. Bone Miner 4:197–216PubMed

26.

Wakamatsu E, Sissons HA (1969) The cancellous bone of the iliac crest. Calcif Tissue Res 4:147–161PubMedCrossRef

27.

Weinstein RS, Hutson MS (1987) Decreased trabecular width and increased trabecular spacing contribute to bone loss with aging. Bone 8:137–142PubMedCrossRef

28.

Vesterby A (1993) Star volume in bone research: a histomorphometric analysis of trabecular bone structure using vertical sections. Anat Rec 235:325–334PubMedCrossRef

29.

Compston JE (1994) Connectivity of cancellous bone: Assessment and mechanical implications. Bone 15:463–466PubMedCrossRef

30.

Mellish RW, Ferguson-Pell MW, Cochran GV, Lindsay R, Dempster DW (1991) A new manual method for assessing two-dimensional cancellous bone structure: comparison between iliac crest and lumbar vertebra. J Bone Miner Res 6:689–696PubMedCrossRef

31.

Tabor Z, Rokita E (2002) Stochastic simulations of remodeling applied to a two-dimensional trabecular bone structure. Bone 31:413–417PubMedCrossRef

32.

Chappard D, Retailleau-Gaborit N, Legrand E, Baslé MF, Audran M (2005) Comparison insight bone measurements by histomorphometry and microCT. J Bone Miner Res 20:1177–1184PubMedCrossRef

33.

Canalis E (1996) Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441–3447PubMedCrossRef

34.

Barbier A, Martel C, de Vernejoul MC, Tirode F, Nys M, Mocaer G, Morieux C, Murakami H, Lacheretz F (1999) The visualization and evaluation of bone architecture in the rat using three-dimensional X-ray microcomputed tomography. J Bone Miner Metab 17:37–44PubMedCrossRef

35.

Hordon LD, Itoda M, Shore PA, Shore RC, Heald M, Brown M, Kanis JA, Rodan GA, Aaron JE (2006) Preservation of thoracic spine microarchitecture by alendronate: comparison of histology and microCT. Bone 38:444–449PubMedCrossRef

36.

Schmidt C, Priemel M, Kohler T, Weusten A, Müller R, Amling M, Eckstein F (2003) Precision and accuracy of peripheral quantitative computed tomography (pQCT) in the mouse skeleton compared with histology and microcomputed tomography (microCT). J Bone Miner Res 18:1486–1496PubMedCrossRef

37.

Alexander JM, Bab I, Fish S, Müller R, Uchiyama T, Gronowicz G, Nahounou M, Zhao Q, White DW, Chorev M, Gazit D, Rosenblatt M (2001) Human parathyroid hormone 1–34 reverses bone loss in ovariectomized mice. J Bone Miner Res 16:1665–1673PubMedCrossRef

38.

Lane NE, Kimmel DB, Nilsson MHL, Cohen FE, Newton S, Nissenson RA, Strewler GJ (1996) Bone-selective analogs of human PTH(1–34) increase bone formation in an ovariectomized rat model. J Bone Miner Res 11:614–625PubMed

39.

Lane NE, Thompson JM, Strewler GJ, Kinney JH (1995) Intermittent treatment with human parathyroid hormone (hPTH[1–34]) increased trabecular bone volume but not connectivity in osteopenic rats. J Bone Miner Res 10:1470–1477PubMed

40.

Weinstein RS, Manolagas SC (2005) Apoptosis in glucocorticosteroid-induced bone disease. Curr Opin Endocrinol Diabetes 12:219–223CrossRef

Title: Bone microarchitecture in males with corticosteroid-induced osteoporosis
Authors: D. Chappard
N. Josselin
C. Rougé-Maillart
E. Legrand
M. F. Baslé
M. Audran
Publication date: 01-04-2007
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 4/2007
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-006-0278-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Bone microarchitecture in males with corticosteroid-induced osteoporosis

Abstract

Summary

Introduction

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2007

How to select the doses of vitamin D in the management of osteoporosis

Balance training program is highly effective in improving functional status and reducing the risk of falls in elderly women with osteoporosis: a randomized controlled trial

The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women

Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?

Determinants of bone mineral density in Chinese-American women

Bone loss in elderly men: increased endosteal bone loss and stable periosteal apposition. The prospective MINOS study